Fatty Liver Disease Treatment by Dr. Chetan Kalal
Fatty liver disease is no longer a “silent incidental finding.”
For many patients, it represents an active metabolic and liver injury process that can progress to fibrosis, cirrhosis, liver failure, or liver cancer if risk is underestimated.
Dr. Chetan Kalal provides evidence-based evaluation and treatment for:
Fatty Liver Disease (NAFLD)
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD/MASH)
Obesity-associated liver disease
Lean fatty liver disease
Advanced fibrosis and cirrhosis related to fatty liver
What Makes Advanced Fatty Liver Care Different?
Many patients are either:
reassured too early,
overtreated unnecessarily,
or diagnosed only after fibrosis has progressed.
Effective fatty liver treatment requires:
fibrosis risk assessment,
metabolic evaluation,
structured weight-loss strategy,
diabetes and lipid optimisation,
liver stiffness interpretation,
and identification of patients at risk of progression.
Comprehensive Fatty Liver Evaluation Includes:
Fibrosis risk stratification
FIB-4 and non-invasive liver assessment
FibroScan interpretation
Metabolic syndrome evaluation
Obesity and insulin resistance assessment
Advanced liver blood test interpretation
Cirrhosis risk prediction
Medication review and treatment optimisation
Advanced Treatment Approach
Treatment plans may include:
medically supervised weight reduction,
nutrition and lifestyle correction,
evidence-based pharmacotherapy,
obesity and diabetes optimisation,
fibrosis monitoring,
and long-term liver risk reduction.
Selected patients may require:
GLP-1–based therapies,
metabolic optimisation,
hepatology-directed surveillance,
or transplant-stage evaluation in advanced disease.
When Should You Seek Expert Review?
Persistent fatty liver despite lifestyle changes
Elevated SGPT/ALT/AST
FibroScan showing fibrosis
Diabetes with fatty liver
Obesity-related liver disease
Family history of cirrhosis
“Normal ultrasound but abnormal liver tests”
Fatty liver with fatigue, swelling, or jaundice
Conflicting treatment advice
Concern regarding progression to cirrhosis
Expert Second Opinions in Fatty Liver Disease
Not all fatty liver patients progress the same way.
The key is identifying:
who can reverse disease early,
who is developing fibrosis silently,
and who requires aggressive intervention before irreversible damage develops.
Consultation & Virtual Care
Available for patients across:
Mumbai
Navi Mumbai
Thane
India
USA
UK
UAE/Dubai
Singapore
Australia
Canada
Middle East & international locations
🌐 drchetankalal.com
Advanced Fatty Liver Disease Care • MASH/NAFLD Management • Fibrosis Assessment • Expert Hepatology Second Opinions
